Advanced search
Publication Cover
Journal of Community Hospital Internal Medicine Perspectives Volume 5, 2015 - Issue 4
Journal homepage
361
Views
1
CrossRef citations to date
0
Altmetric
Letters to the Editor

Sodium zirconium cyclosilicate (ZS-9) treatment in patients with serum potassium >6.5 mEq/L

Henrik RasmussenZS Pharma, Inc., 508 Wrangler Drive, Suite 100, Coppell, TX 75019, USACorrespondence[email protected]
, MD, PhD
Article: 29097 | Published online: 01 Sep 2015

References

  • Karmacharya P, Poudel RD, Pathak R, Rettew A, Alweis R. Acute hyperkalemia leading to flaccid paralysis: A review of hyperkalemic manifestations. J Community Hosp Intern Med Perspect. 2015; 5(3): 27993. doi: http://dx.doi.org/10.3402/jchimp.v5.27993..
  • Kosiborod M, Rasmussen HS, Lavin P, Wajeh Y, Qunibi WY, Spinowitz BS, etal. Effect of sodium zirconium cyclosilicate on potassium lowering for 28 days among outpatients with hyperkalemia: The HARMONIZE randomized clinical trial. JAMA. 2014; 312(21): 2223–33. doi: 10.1001/jama.2014.15688..
  • Kosiborod M, Peacock WF, Packham DK. Sodium zirconium cyclosilicate for urgent therapy of severe hyperkalemia. N Engl J Med. 2015; 372(16): 1577–8. doi: 10.1056/NEJMc1500353..

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.